Literature DB >> 3016754

Leukotriene B4 and 20-OH-LTB4 in purulent peritoneal exudates demonstrated by GC-MS.

Y Kikawa, Y Shigematsu, M Sudo.   

Abstract

Inflammatory peritoneal exudates from 11 patients with purulent peritonitis or non-perforative appendicitis were analyzed by gas chromatography mass spectrometry (GC-MS) for their content of 5S, 12R-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid (LTB4) and its omega-oxidized catabolite, 5S,12R,20-trihydroxy-6,8,10,14-eicosatetraenoic acid (20-OH-LTB4). Eleven samples of peritoneal exudates were examined. LTB4 and 20-OH-LTB4 were demonstrated only in the samples from patients with purulent peritonitis. LTB4 was detected in 4 samples, and 20-OH-LTB4 was detected in 6 samples by GC-MS with selected ion monitoring. In addition, a nearly full spectrum corresponding to that of synthetic 20-OH-LTB4 was obtained with 3 samples. Neither LTB4 nor 20-OH-LTB4 were detected in samples from patients with non-perforative appendicitis. LTB4 or 20-OH-LTB4 may be related to the pathophysiological mechanism of purulent inflammations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016754     DOI: 10.1016/0262-1746(86)90080-6

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  3 in total

1.  Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.

Authors:  E R Pettipher; E D Salter; R Breslow; L Raycroft; H J Showell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

2.  Leukotriene B4 production in children with steroid-responsive nephrotic syndrome.

Authors:  Y Kikawa; A Nakai; Y Shigematsu; M Sudo; K Kato; S Haruki
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

3.  Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits.

Authors:  S Marleau; N Dallaire; P E Poubelle; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.